Meta-Review of Protein Network Regulating Obesity Between Validated Obesity Candidate Genes in the White Adipose Tissue of High-Fat Diet-Induced Obese C57BL/6J Mice

Worldwide obesity and related comorbidities are increasing, but identifying new therapeutic targets remains a challenge. A plethora of microarray studies in diet-induced obesity models has provided large datasets of obesity associated genes. In this review, we describe an approach to examine the underlying molecular network regulating obesity, and we discuss interactions between obesity candidate genes. We conducted network analysis on functional protein–protein interactions associated with 25 obesity candidate genes identified in a literature-driven approach based on published microarray studies of diet-induced obesity. The obesity candidate genes were closely associated with lipid metabolism and inflammation. Peroxisome proliferator activated receptor gamma (Pparg) appeared to be a core obesity gene, and obesity candidate genes were highly interconnected, suggesting a coordinately regulated molecular network in adipose tissue. In conclusion, the current network analysis approach may help elucidate the underlying molecular network regulating obesity and identify anti-obesity targets for therapeutic intervention.

[1]  H. Petry,et al.  Molecular therapy for obesity and diabetes based on a long‐term increase in hepatic fatty‐acid oxidation , 2011, Hepatology.

[2]  M. Yin,et al.  Histidine and carnosine alleviated hepatic steatosis in mice consumed high saturated fat diet. , 2011, European journal of pharmacology.

[3]  C. Dray,et al.  Cathepsin-D, a Key Protease in Breast Cancer, Is Up-Regulated in Obese Mouse and Human Adipose Tissue, and Controls Adipogenesis , 2011, PloS one.

[4]  A. Lichtenstein,et al.  Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. , 2010, The Journal of nutrition.

[5]  Roger D. Cox,et al.  Overexpression of Fto leads to increased food intake and results in obesity , 2010, Nature Genetics.

[6]  T. Park,et al.  Diet-induced obesity regulates the galanin-mediated signaling cascade in the adipose tissue of mice. , 2010, Molecular nutrition & food research.

[7]  J. Um,et al.  Gamiwalbitang, composed of four herbs, controls body weight increase and lipid level elevation induced by a high-fat diet in mice , 2010, Immunopharmacology and immunotoxicology.

[8]  G. Shulman,et al.  Resistance to high-fat diet-induced obesity and insulin resistance in mice with very long-chain acyl-CoA dehydrogenase deficiency. , 2010, Cell metabolism.

[9]  I. Han,et al.  Dietary Capsaicin Reduces Obesity‐induced Insulin Resistance and Hepatic Steatosis in Obese Mice Fed a High‐fat Diet , 2010, Obesity.

[10]  G. Steinberg,et al.  Adipose tissue as an endocrine organ , 2010, Molecular and Cellular Endocrinology.

[11]  Dorothy D. Sears,et al.  Functional Heterogeneity of CD11c-positive Adipose Tissue Macrophages in Diet-induced Obese Mice* , 2010, The Journal of Biological Chemistry.

[12]  S. Keller,et al.  Valsartan Protects Pancreatic Islets and Adipose Tissue From the Inflammatory and Metabolic Consequences of a High-Fat Diet in Mice , 2010, Hypertension.

[13]  K. Huggins,et al.  Consumption of a high glycemic index diet increases abdominal adiposity but does not influence adipose tissue pro-oxidant and antioxidant gene expression in C57BL/6 mice. , 2010, Nutrition research.

[14]  Jan Nedergaard,et al.  Chronic Peroxisome Proliferator-activated Receptor γ (PPARγ) Activation of Epididymally Derived White Adipocyte Cultures Reveals a Population of Thermogenically Competent, UCP1-containing Adipocytes Molecularly Distinct from Classic Brown Adipocytes* , 2009, The Journal of Biological Chemistry.

[15]  S. Yanovski,et al.  The FTO gene rs9939609 obesity-risk allele and loss of control over eating. , 2009, The American journal of clinical nutrition.

[16]  Mi-Ja Kim,et al.  Perilla leaf extract ameliorates obesity and dyslipidemia induced by high‐fat diet , 2009, Phytotherapy research : PTR.

[17]  K. Nakao,et al.  Effects of coffee on inflammatory cytokine gene expression in mice fed high-fat diets. , 2009, Journal of agricultural and food chemistry.

[18]  Y. Tomino,et al.  Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice. , 2009, Metabolism: clinical and experimental.

[19]  R. Marfella,et al.  Effect of weight loss on coronary circulation and adiponectin levels in obese women. , 2009, International journal of cardiology.

[20]  I. Hwang,et al.  Comparative Study on High Fat Diet-induced 4-Hydroxy-2E-nonenal Adducts in the Hippocampal CA1 Region of C57BL/6N and C3H/HeN Mice , 2009, Neurochemical Research.

[21]  J. Ordovás ABC1: the gene for Tangier disease and beyond. , 2009, Nutrition reviews.

[22]  N. Bardeesy,et al.  Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway. , 2009, Biochemical and biophysical research communications.

[23]  Jens C. Brüning,et al.  Inactivation of the Fto gene protects from obesity , 2009, Nature.

[24]  H. Joost,et al.  Angiogenesis in the New Zealand obese mouse model fed with high fat diet , 2009, Lipids in Health and Disease.

[25]  N. Stefan,et al.  Variation in the FTO gene influences food intake but not energy expenditure. , 2008, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[26]  T. Mendoza,et al.  Mesoderm‐specific transcript is associated with fat mass expansion in response to a positive energy balance , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  J. Speakman,et al.  Polymorphisms of the FTO Gene Are Associated With Variation in Energy Intake, but not Energy Expenditure , 2008, Obesity.

[28]  T. Park,et al.  Garcinia cambogia Extract Ameliorates Visceral Adiposity in C57BL/6J Mice Fed on a High-Fat Diet , 2008, Bioscience, biotechnology, and biochemistry.

[29]  T. Park,et al.  Genes are differentially expressed in the epididymal fat of rats rendered obese by a high-fat diet. , 2008, Nutrition research.

[30]  D. Bessesen Update on obesity. , 2008, The Journal of clinical endocrinology and metabolism.

[31]  L. Vanderschuren,et al.  Anti-obesity drugs and neural circuits of feeding. , 2008, Trends in pharmacological sciences.

[32]  H. Wyatt,et al.  International strategies to address obesity , 2008, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[33]  M. Czech,et al.  Stearoyl-CoA Desaturase 2 Is Required for Peroxisome Proliferator-activated Receptor γ Expression and Adipogenesis in Cultured 3T3-L1 Cells* , 2008, Journal of Biological Chemistry.

[34]  M. Laville,et al.  Changes in Gene Expression in Skeletal Muscle in Response to Fat Overfeeding in Lean Men , 2007, Obesity.

[35]  J. Eriksson Metabolic stress in insulin's target cells leads to ROS accumulation – A hypothetical common pathway causing insulin resistance , 2007, FEBS letters.

[36]  Terence E. Ryan,et al.  Adipose Mitochondrial Biogenesis Is Suppressed in db/db and High-Fat Diet–Fed Mice and Improved by Rosiglitazone , 2007, Diabetes.

[37]  W. Wahli,et al.  Fat poetry: a kingdom for PPARγ , 2007, Cell Research.

[38]  Y. Aggoun,et al.  Obesity, Metabolic Syndrome, and Cardiovascular Disease , 2007, Pediatric Research.

[39]  M. Jarvelin,et al.  A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.

[40]  M. Matsuda,et al.  Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation , 2007, Diabetes.

[41]  Arya M. Sharma,et al.  Peroxisome Proliferator-Activated Receptor γ and Adipose Tissue—Understanding Obesity-Related Changes in Regulation of Lipid and Glucose Metabolism , 2007 .

[42]  R. S. Kiss,et al.  Cathepsin D, a Lysosomal Protease, Regulates ABCA1-mediated Lipid Efflux* , 2006, Journal of Biological Chemistry.

[43]  Z. Madar,et al.  A High‐Fat Diet Has a Tissue‐Specific Effect on Adiponectin and Related Enzyme Expression , 2006, Obesity.

[44]  T. Funahashi,et al.  Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[45]  M. Alessi,et al.  PAI-1 and the Metabolic Syndrome: Links, Causes, and Consequences , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[46]  T. Kadowaki,et al.  Overexpression of Monocyte Chemoattractant Protein-1 in Adipose Tissues Causes Macrophage Recruitment and Insulin Resistance* , 2006, Journal of Biological Chemistry.

[47]  Zhi-gang Guo,et al.  [Modulation of inflammatory cytokines by ATP-binding cassette A1 in THP-1 macrophages]. , 2006, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[48]  R. Kitazawa,et al.  MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.

[49]  E. Mannarino,et al.  The endocrine function of adipose tissue: an update , 2006, Clinical endocrinology.

[50]  Somesh D. Sharma,et al.  Peroxisome proliferator-activated receptor-α selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice , 2006, Molecular and Cellular Biochemistry.

[51]  F. Milagro,et al.  Differential expression of aquaporin 7 in adipose tissue of lean and obese high fat consumers. , 2006, Biochemical and biophysical research communications.

[52]  R. Leibel,et al.  CCR2 modulates inflammatory and metabolic effects of high-fat feeding. , 2006, The Journal of clinical investigation.

[53]  H. Joost,et al.  Nutrition-/diet-induced changes in gene expression in white adipose tissue. , 2005, Best practice & research. Clinical endocrinology & metabolism.

[54]  M. Cowley,et al.  Is ghrelin a signal for the development of metabolic systems? , 2005, The Journal of clinical investigation.

[55]  W. Ling,et al.  Globular adiponectin decreases leptin-induced tumor necrosis factor-alpha expression by murine macrophages: involvement of cAMP-PKA and MAPK pathways. , 2005, Cellular immunology.

[56]  P. Flachs,et al.  Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce β-oxidation in white fat , 2005, Diabetologia.

[57]  Chunsheng Zhang,et al.  Diet induction of monocyte chemoattractant protein-1 and its impact on obesity. , 2005, Obesity research.

[58]  D. Loskutoff,et al.  Molecular mechanisms of tumor necrosis factor‐α‐mediated plasminogen activator inhibitor‐1 expression in adipocytes , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[59]  F. Karpe,et al.  Adipose tissue fatty acid metabolism and cardiovascular disease , 2005, Current opinion in lipidology.

[60]  Joseph L Evans,et al.  The molecular basis for oxidative stress-induced insulin resistance. , 2005, Antioxidants & redox signaling.

[61]  Nikolaus Marx,et al.  Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer study. , 2005, Journal of the American College of Cardiology.

[62]  Jiyoung Park,et al.  Overexpression of Glucose-6-Phosphate Dehydrogenase Is Associated with Lipid Dysregulation and Insulin Resistance in Obesity , 2005, Molecular and Cellular Biology.

[63]  J. Pennings,et al.  Adipose gene expression patterns of weight gain suggest counteracting steroid hormone synthesis. , 2005, Obesity research.

[64]  K. Wellen,et al.  Inflammation, stress, and diabetes. , 2005, The Journal of clinical investigation.

[65]  H. Hauner Secretory factors from human adipose tissue and their functional role , 2005, Proceedings of the Nutrition Society.

[66]  R. Kesterson,et al.  Deletion of PPARγ in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[67]  S. B. Pedersen,et al.  Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. , 2005, The Journal of clinical endocrinology and metabolism.

[68]  S. Farmer,et al.  Regulation of PPARγ activity during adipogenesis , 2005, International Journal of Obesity.

[69]  H. Hauner,et al.  Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1 , 2004, International Journal of Obesity.

[70]  R. Robertson Chronic Oxidative Stress as a Central Mechanism for Glucose Toxicity in Pancreatic Islet Beta Cells in Diabetes* , 2004, Journal of Biological Chemistry.

[71]  L. Qiang,et al.  Phosphorylation of C/EBPβ at a Consensus Extracellular Signal-Regulated Kinase/Glycogen Synthase Kinase 3 Site Is Required for the Induction of Adiponectin Gene Expression during the Differentiation of Mouse Fibroblasts into Adipocytes , 2004, Molecular and Cellular Biology.

[72]  I. S. Wood,et al.  Adipokines: inflammation and the pleiotropic role of white adipose tissue , 2004, British Journal of Nutrition.

[73]  Friedrich Spener,et al.  Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins. , 2004, The Biochemical journal.

[74]  Y. Deshaies,et al.  Peroxisome Proliferator-Activated Receptor γ Agonism Increases the Capacity for Sympathetically Mediated Thermogenesis in Lean and ob/ob Mice , 2004 .

[75]  M. Cowley,et al.  Ghrelin--satisfying a hunger for the mechanism. , 2004, Endocrinology.

[76]  H. M. Moon,et al.  Adipocyte Determination- and Differentiation-dependent Factor 1/Sterol Regulatory Element-binding Protein 1c Regulates Mouse Adiponectin Expression* , 2004, Journal of Biological Chemistry.

[77]  A. Madan,et al.  Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. , 2004, Endocrinology.

[78]  J. Flier,et al.  Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. , 2004, Diabetes.

[79]  P. Ferré,et al.  The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. , 2004, Diabetes.

[80]  M. Guerre-Millo Adipose tissue and adipokines: for better or worse. , 2004, Diabetes & metabolism.

[81]  J. Flier Obesity Wars Molecular Progress Confronts an Expanding Epidemic , 2004, Cell.

[82]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[83]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[84]  K. Wellen,et al.  Obesity-induced inflammatory changes in adipose tissue. , 2003, The Journal of clinical investigation.

[85]  Johan Auwerx,et al.  Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[86]  Weimin He,et al.  Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[87]  F. Kraemer,et al.  Resistance to high-fat diet-induced obesity and altered expression of adipose-specific genes in HSL-deficient mice. , 2003, American journal of physiology. Endocrinology and metabolism.

[88]  T. Orntoft,et al.  Study of the alteration of gene expression in adipose tissue of diet-induced obese mice by microarray and reverse transcription-polymerase chain reaction analyses. , 2003, Endocrinology.

[89]  S. Ishibashi,et al.  Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. , 2003, Metabolism: clinical and experimental.

[90]  M. Reitman,et al.  Liver Peroxisome Proliferator-activated Receptor γ Contributes to Hepatic Steatosis, Triglyceride Clearance, and Regulation of Body Fat Mass* , 2003, Journal of Biological Chemistry.

[91]  P. Scherer,et al.  Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0580 Minireview: The Adipocyte—At the Crossroads of Energy Homeostasis, Inflammation, and Atherosclerosis , 2022 .

[92]  G. Winkler,et al.  Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. , 2003, European journal of endocrinology.

[93]  R. Henry,et al.  Adiponectin: more than just another fat cell hormone? , 2003, Diabetes care.

[94]  P. Morange,et al.  Plasminogen activator inhibitor‐1, inflammation, obesity, insulin resistance and vascular risk , 2003, Journal of thrombosis and haemostasis : JTH.

[95]  M. Mozzoli,et al.  Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes. , 2003, Metabolism: clinical and experimental.

[96]  J. Hallenbeck,et al.  Overexpression of Monocyte Chemoattractant Protein 1 in the Brain Exacerbates Ischemic Brain Injury and is Associated with Recruitment of Inflammatory Cells , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[97]  J. Friedman A War on Obesity, Not the Obese , 2003, Science.

[98]  I. P. López,et al.  DNA microarray analysis of genes differentially expressed in diet-induced (cafeteria) obese rats. , 2003, Obesity research.

[99]  S. Uchida,et al.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature Medicine.

[100]  Joseph L Evans,et al.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. , 2002, Endocrine reviews.

[101]  O. Ukkola,et al.  Adiponectin: a link between excess adiposity and associated comorbidities? , 2002, Journal of Molecular Medicine.

[102]  T. Mariani,et al.  Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. , 2002, Free radical biology & medicine.

[103]  K. Frayn,et al.  Adipose tissue as a buffer for daily lipid flux , 2002, Diabetologia.

[104]  P. Garcia-Lorda,et al.  TNFα expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipocyte LPL activity and leptin synthesis , 2002, International Journal of Obesity.

[105]  E. Bruckert,et al.  Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. , 2002, The Journal of clinical endocrinology and metabolism.

[106]  M. Kouach,et al.  Endosomal Proteolysis of Internalized Insulin at the C-terminal Region of the B Chain by Cathepsin D* , 2002, The Journal of Biological Chemistry.

[107]  S. Tilghman,et al.  A mutation in the peroxisome proliferator-activated receptor γ-binding site in the gene for the cytosolic form of phosphoenolpyruvate carboxykinase reduces adipose tissue size and fat content in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[108]  M. Lane,et al.  Downregulation of repressive CUP/AP-2 isoforms during adipocyte differentiation. , 2001, Biochemical and biophysical research communications.

[109]  B. Spiegelman,et al.  PPARγ: a Nuclear Regulator of Metabolism, Differentiation, and Cell Growth* , 2001, The Journal of Biological Chemistry.

[110]  J. Filmus,et al.  Transforming Growth Factor-α Prevents Detachment-induced Inhibition of c-Src Kinase Activity, Bcl-XLDown-regulation, and Apoptosis of Intestinal Epithelial Cells* , 2001, The Journal of Biological Chemistry.

[111]  W. Wahli,et al.  Printed in U.S.A. Copyright © 2001 by The Endocrine Society Rat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding , 2022 .

[112]  Barbara D. Saatkamp,et al.  Distinct Transcriptional Profiles of Adipogenesisin Vivo and in Vitro * , 2001, The Journal of Biological Chemistry.

[113]  B. McManus,et al.  Hepatic over-expression of peroxisome proliferator activated receptor γ2 in the ob/ob mouse model of non‐insulin dependent diabetes mellitus , 2001, Molecular and Cellular Biochemistry.

[114]  T. Funahashi,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .

[115]  T. Funahashi,et al.  Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. , 2001, Diabetes.

[116]  T. Langmann,et al.  Structure, function and regulation of the ABC1 gene product , 2001, Current opinion in lipidology.

[117]  T. Willson,et al.  Comprehensive Messenger Ribonucleic Acid Profiling Reveals That Peroxisome Proliferator-Activated Receptor γ Activation Has Coordinate Effects on Gene Expression in Multiple Insulin-Sensitive Tissues. , 2001, Endocrinology.

[118]  Bruce M. Spiegelman,et al.  Obesity and the Regulation of Energy Balance , 2001, Cell.

[119]  R. Bergman,et al.  Central Role of the Adipocyte in the Metabolic Syndrome , 2001, Journal of Investigative Medicine.

[120]  R. Morrison,et al.  Hormonal signaling and transcriptional control of adipocyte differentiation. , 2000, The Journal of nutrition.

[121]  B. Wajchenberg Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. , 2000, Endocrine reviews.

[122]  B. Yandell,et al.  The expression of adipogenic genes is decreased in obesity and diabetes mellitus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[123]  P. Morange,et al.  Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. , 2000, Diabetes.

[124]  P. Puigserver,et al.  Transcriptional regulation of adipogenesis. , 2000, Genes & development.

[125]  A. Vaughan,et al.  ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. , 2000, Current opinion in lipidology.

[126]  N. Socci,et al.  Leptin-specific patterns of gene expression in white adipose tissue. , 2000, Genes & development.

[127]  B. Spiegelman,et al.  Cross-Regulation of C/EBPα and PPARγ Controls the Transcriptional Pathway of Adipogenesis and Insulin Sensitivity , 1999 .

[128]  B. Spiegelman,et al.  ADD1/SREBP1 activates PPARγ through the production of endogenous ligand , 1998 .

[129]  M. Lane,et al.  Derepression of the C/EBPα gene during adipogenesis: Identification of AP-2α as a repressor , 1998 .

[130]  S. O’Rahilly,et al.  Tumor Necrosis Factor-α Induces Apoptosis of Human Adipose Cells , 1997, Diabetes.

[131]  J. Gimble,et al.  CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor gamma 2 promoter. , 1997, Biochemical and biophysical research communications.

[132]  J Auwerx,et al.  PPARalpha and PPARgamma activators direct a distinct tissue‐specific transcriptional response via a PPRE in the lipoprotein lipase gene. , 1996, The EMBO journal.

[133]  W. Gong,et al.  Human recombinant monocyte chemotactic protein and other c‐c chemokines bind and induce directional migration of dendritic cells in vitro , 1996, Journal of leukocyte biology.

[134]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[135]  B. Lowell,et al.  Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action , 1995, Nature Medicine.

[136]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.

[137]  B. Spiegelman,et al.  PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene , 1995, Molecular and cellular biology.

[138]  M. Lazar,et al.  Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. , 1994, Endocrinology.

[139]  S. Freytag,et al.  Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells. , 1994, Genes & development.

[140]  B. Spiegelman,et al.  mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. , 1994, Genes & development.

[141]  F. Denizot,et al.  Cloning of two novel ABC transporters mapping on human chromosome 9. , 1994, Genomics.

[142]  T. Springer,et al.  Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[143]  A. Admon,et al.  SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene , 1993, Cell.

[144]  Christine Dreyer,et al.  Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors , 1992, Cell.

[145]  I. Issemann,et al.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators , 1990, Nature.

[146]  J. Vilček,et al.  Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence , 1990, Molecular and cellular biology.

[147]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[148]  K. Kaestner,et al.  Differentiation-induced gene expression in 3T3-L1 preadipocytes. A second differentially expressed gene encoding stearoyl-CoA desaturase. , 1989, The Journal of biological chemistry.

[149]  K. Kaestner,et al.  Differentiation-induced gene expression in 3T3-L1 preadipocytes. Characterization of a differentially expressed gene encoding stearoyl-CoA desaturase. , 1988, The Journal of biological chemistry.

[150]  Liu Qion Subcutaneous and visceral adipose tissue , 2013 .

[151]  Olly Renaldi,et al.  Hypoadiponectinemia: a risk factor for metabolic syndrome. , 2009, Acta medica Indonesiana.

[152]  W. Wahli,et al.  Fat poetry: a kingdom for PPAR gamma. , 2007, Cell research.

[153]  M. Matsuda,et al.  Thiazolidinediones improve beta-cell function in type 2 diabetic patients. , 2007, American journal of physiology. Endocrinology and metabolism.

[154]  Arya M. Sharma,et al.  Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism. , 2007, The Journal of clinical endocrinology and metabolism.

[155]  Somesh D. Sharma,et al.  Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice. , 2006, Molecular and cellular biochemistry.

[156]  R. Kesterson,et al.  Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[157]  S. Farmer Regulation of PPARgamma activity during adipogenesis. , 2005, International journal of obesity.

[158]  Y. Deshaies,et al.  Peroxisome proliferator-activated receptor gamma agonism increases the capacity for sympathetically mediated thermogenesis in lean and ob/ob mice. , 2004, Endocrinology.

[159]  J. Auwerx,et al.  Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[160]  B. Spiegelman,et al.  PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth. , 2001, The Journal of biological chemistry.

[161]  T. Willson,et al.  Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues. , 2001, Endocrinology.

[162]  Z. Spolarics A carbohydrate-rich diet stimulates glucose-6-phosphate dehydrogenase expression in rat hepatic sinusoidal endothelial cells. , 1999, The Journal of nutrition.

[163]  M. Lane,et al.  Derepression of the C/EBPalpha gene during adipogenesis: identification of AP-2alpha as a repressor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[164]  B. Spiegelman,et al.  ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[165]  J. E. Silva,et al.  Thiazolidinediones stimulate uncoupling protein-2 expression in cell lines representing white and brown adipose tissues and skeletal muscle. , 1998, Endocrinology.

[166]  C. Niesler,et al.  Tumor necrosis factor-alpha induces apoptosis of human adipose cells. , 1997, Diabetes.

[167]  K. Tracey,et al.  Tumor necrosis factor, other cytokines and disease. , 1993, Annual review of cell biology.

[168]  J. Van Snick Interleukin-6: an overview. , 1990, Annual review of immunology.

[169]  D. Nicholls,et al.  The identification of the component in the inner membrane of brown adipose tissue mitochondria responsible for regulating energy dissipation. , 1978, Experientia. Supplementum.